Cat's Claw (Uncaria tomentosa)

Table of Contents

1. Amazonian History and Traditional Use
2. Key Antibacterial Compounds
3. Mechanism of Antibacterial Action
4. Bacteria Targeted
5. Research Studies and Clinical Evidence
6. Immune System Enhancement
7. Anti-Inflammatory and Antibacterial Synergy
8. Lyme Disease and Tick-Borne Infections
9. Gastrointestinal Health
10. DNA Repair and Cellular Protection
11. Two Chemotypes
12. Synergistic Effects
13. Other Health Benefits
14. Forms and Preparations
15. Doses Used in Studies and Practice
16. Safety and Contraindications
17. Key Research Papers
18. Featured Videos

Amazonian History and Traditional Use

Cat's claw, known in Spanish as uña de gato for the small hook-shaped thorns that resemble a cat's claws, is a woody vine of the Peruvian Amazon with no place in the ancient medicine of the Old World. Its documented story belongs to the indigenous peoples of the rainforest — above all the Asháninka, who used the simmered inner bark for inflammation, infection, digestion, and recovery from illness — and to the twentieth-century travellers and scientists, notably the Austrian Klaus Keplinger from the 1970s, who carried that knowledge to the wider world. — the fuller story is told in the dedicated History & Traditional Use article.

Key Antibacterial Compounds

The antibacterial and immune-modulating activity of cat's claw stems from a complex phytochemical profile that includes several distinct classes of bioactive compounds. Researchers have identified over 50 individual compounds in the bark and root, with the following being the most therapeutically significant for antibacterial and immune-related activity.

• Oxindole alkaloids: These are the most studied and pharmacologically active compounds in cat's claw. The key oxindole alkaloids include:
  • Isopteropodine: The most abundant alkaloid in pentacyclic chemotypes, reported to enhance phagocytosis in laboratory studies. It acts as a potent immune stimulant that increases the capacity of white blood cells to engulf and destroy bacteria and other pathogens.
  • Pteropodine: Demonstrates immunomodulatory activity and has been shown to interact with muscarinic and serotonergic receptors. Research indicates pteropodine enhances the ability of macrophages and granulocytes to attack bacterial invaders.
  • Mitraphylline: Exhibits anti-inflammatory, muscle relaxant, and diuretic properties. Studies have found that mitraphylline inhibits the proliferation of certain cancer cell lines while simultaneously supporting immune cell activity against infections.
  • Uncarine F: Contributes to the overall immune-enhancing profile of cat's claw and has demonstrated activity in increasing lymphocyte proliferation, which is critical for mounting adaptive immune responses against bacterial infections.
• Quinovic acid glycosides: These triterpenoid compounds exhibit direct antimicrobial and antiviral activity. Research has identified at least seven distinct quinovic acid glycosides in cat's claw, with several showing measurable antibacterial effects against gram-positive and gram-negative bacteria in vitro. Quinovic acid glycosides also demonstrate anti-inflammatory activity that complements the alkaloid fraction.
• Proanthocyanidins: Cat's claw contains significant concentrations of proanthocyanidins (condensed tannins), which are powerful antioxidant and antimicrobial compounds. Proanthocyanidins exert antibacterial effects by disrupting bacterial cell membranes, chelating metal ions essential for bacterial metabolism, and inhibiting bacterial enzymes. These compounds also support the integrity of the gut lining, helping to prevent translocation of bacteria from the intestine into the bloodstream.
• Polyphenols and flavonoids: Including catechin, epicatechin, and procyanidins, these compounds provide additional antioxidant protection and have demonstrated antibacterial activity in their own right. They also enhance the bioavailability and activity of the alkaloid and glycoside fractions.
• Sterols and triterpenes: Beta-sitosterol, stigmasterol, and campesterol contribute to anti-inflammatory and immune-modulating effects, supporting the body's overall capacity to combat bacterial infections.

Mechanism of Antibacterial Action

Cat's claw fights bacterial infections through a multifaceted approach that combines immune system enhancement with direct antibacterial activity and modulation of inflammatory pathways. Understanding these mechanisms is essential for appreciating why cat's claw is valued as a systemic immune tonic rather than a simple antimicrobial agent.

• Immune enhancement as the primary mechanism: Unlike conventional antibiotics that directly kill bacteria, cat's claw works primarily by amplifying the body's own immune defenses. The oxindole alkaloids increase the production and activity of white blood cells, enhance phagocytosis (the process by which immune cells engulf and destroy pathogens), and stimulate the release of cytokines that coordinate the immune response. This approach means that cat's claw helps the body fight infections naturally, reducing the risk of antibiotic resistance while addressing the underlying immune weakness that allowed the infection to take hold.
• Direct antibacterial activity: While immune enhancement is the predominant mechanism, several cat's claw compounds demonstrate direct antibacterial effects in laboratory settings. Quinovic acid glycosides and proanthocyanidins can disrupt bacterial cell walls and membranes, interfere with bacterial enzyme systems, and inhibit bacterial adhesion to host tissues. These direct effects are generally modest compared to pharmaceutical antibiotics but contribute to the plant's overall antimicrobial profile, particularly when combined with immune stimulation.
• NF-kB modulation: Cat's claw alkaloids are potent inhibitors of nuclear factor kappa-B (NF-kB), a transcription factor that plays a central role in inflammation and immune regulation. By modulating NF-kB activity, cat's claw achieves a nuanced effect: it reduces excessive inflammation (which can impair immune function and cause tissue damage) while simultaneously enhancing the targeted immune responses needed to eliminate bacteria. This dual action is particularly valuable in chronic infections where persistent inflammation has become part of the disease process rather than part of the solution.
• Biofilm disruption potential: Emerging research suggests that certain cat's claw compounds may interfere with bacterial biofilm formation, the protective matrix that many pathogenic bacteria create to shield themselves from both immune attack and antibiotic treatment. This mechanism is of particular interest in the context of chronic infections where biofilm-associated bacteria are notoriously difficult to eradicate.

Bacteria Targeted

Research has investigated cat's claw's effects against a range of pathogenic bacteria. It is important to note that for most of these organisms, cat's claw works primarily through immune enhancement rather than direct bactericidal action. The following bacteria have been studied in relation to cat's claw's therapeutic activity.

• Staphylococcus aureus: A gram-positive bacterium responsible for skin infections, pneumonia, endocarditis, and sepsis. Cat's claw extracts have demonstrated activity against S. aureus in vitro, with quinovic acid glycosides and proanthocyanidins showing the most pronounced direct effects. The immune-enhancing action of cat's claw alkaloids further supports the body's ability to control staphylococcal infections by increasing neutrophil and macrophage activity. Research published in the Journal of Ethnopharmacology documented measurable inhibition zones against S. aureus from cat's claw bark extracts.
• Enterococcus faecalis: A gram-positive bacterium commonly implicated in urinary tract infections, endocarditis, and wound infections. E. faecalis is particularly problematic because many strains have developed resistance to multiple antibiotics, including vancomycin (VRE). Cat's claw has shown activity against this organism in laboratory studies, making it of interest as a complementary approach for enterococcal infections, particularly given the traditional Amazonian use of the plant for urinary tract complaints.
• Escherichia coli: A gram-negative bacterium that is the most common cause of urinary tract infections and a frequent cause of gastrointestinal illness. Cat's claw extracts have demonstrated moderate inhibitory activity against E. coli in vitro, and the plant's immune-enhancing properties support the body's natural defenses against enteric infections. The proanthocyanidins in cat's claw may also help prevent E. coli adhesion to urinary tract epithelial cells, similar to the mechanism attributed to cranberry proanthocyanidins.
• Pseudomonas aeruginosa: A gram-negative opportunistic pathogen that causes serious infections in immunocompromised individuals, including hospital-acquired pneumonia, burn wound infections, and chronic lung infections in cystic fibrosis patients. P. aeruginosa is intrinsically resistant to many antibiotics and readily forms biofilms. Cat's claw's ability to enhance immune function is particularly relevant for this organism, as host immune status is the primary determinant of susceptibility to pseudomonal infections.
• Helicobacter pylori: A gram-negative spiral bacterium that colonizes the stomach lining, causing chronic gastritis, peptic ulcers, and increasing the risk of gastric cancer. Cat's claw has a long traditional history of treating gastric complaints, and herbal practitioners describe modest direct activity against H. pylori along with gastroprotective effects. The anti-inflammatory and mucosal healing properties of cat's claw are particularly beneficial in the context of H. pylori-associated gastritis, where inflammation is a key driver of tissue damage.

Research Studies and Clinical Evidence

Scientific investigation of cat's claw has intensified since the 1990s, with hundreds of published studies examining its pharmacological properties. While much of the research has been conducted in vitro or in animal models, several notable human clinical trials and significant laboratory studies have contributed to the evidence base.

• Journal of Ethnopharmacology: Multiple studies published in this journal have evaluated the antimicrobial activity of Uncaria tomentosa extracts. A 2005 screening study in this journal included a cat's claw ethanol extract among nine Peruvian plants traditionally used for infections (other plants in the panel were the most active), and a separate 2005 laboratory study, published in Zeitschrift für Naturforschung C, traced cat's claw's activity against gram-positive bacteria to one of its alkaloids, isopteropodine. Another study in the same journal systematically documented the traditional uses of cat's claw among Peruvian indigenous communities, providing ethnobotanical validation for its antimicrobial applications and confirming that treatment of infections was among the most commonly cited traditional uses.
• Planta Medica and Phytomedicine: Key laboratory studies have examined the immunomodulatory mechanisms of cat's claw alkaloids. A 1998 study by Wurm et al. in Planta Medica found that pentacyclic oxindole alkaloids made human endothelial cells (the cells lining blood vessels) release a still-unidentified factor that significantly increased the multiplication of resting or weakly activated human B and T lymphocytes (white blood cells); tetracyclic alkaloids reduced this effect. An earlier 1985 study in the same journal described a phagocytosis-stimulating action of the cat's claw alkaloids. Practitioners see these findings as a basis for the plant's traditional use against infections. Subsequent studies in Phytomedicine confirmed that cat's claw extracts enhance the production of interleukin-1 and interleukin-6, cytokines that play critical roles in orchestrating immune responses to bacterial infections.
• Journal of Natural Products: Research published here has focused on the isolation and characterization of individual bioactive compounds. Studies have identified and characterized the oxindole alkaloids, quinovic acid glycosides, and other compounds responsible for cat's claw's biological activity. Studies by Aquino et al. isolated specific quinovic acid glycosides from the bark: a 1989 study tested them for antiviral activity in the laboratory, and a 1991 study identified a new quinovic acid glycoside as one of the active anti-inflammatory principles (it reduced paw swelling in rats). Together they show that cat's claw contains anti-inflammatory and antiviral compounds as well as immune-stimulating ones.
• Clinical trials: The human studies of a water-soluble (hot-water) cat's claw extract are small. In a 2001 study in Phytomedicine, 12 healthy adults were randomly assigned to three groups (250 mg a day, 350 mg a day, or no supplement) for eight weeks; the two supplemented groups showed a statistically significant decrease in DNA damage and increase in DNA repair, with no toxic effects. In an earlier 2000 study in the Journal of Ethnopharmacology, four healthy men took the extract (5 mg per kg of body weight a day) for six weeks, with no placebo group, and their white blood cell counts rose significantly. Practitioners take these findings as support for cat's claw's use in helping the body detect and clear infections. Small clinical trials in rheumatoid arthritis and knee osteoarthritis, conditions involving both immune dysregulation and inflammation, are described under Other Health Benefits below.

Immune System Enhancement

The immunostimulatory properties of cat's claw represent its most well-documented and clinically significant therapeutic effect. The plant acts on multiple components of both the innate and adaptive immune systems, providing broad-spectrum immune support that is particularly relevant for combating bacterial infections.

• White blood cell stimulation: Cat's claw alkaloids, particularly isopteropodine, have been shown to increase the production of leukocytes (white blood cells) in bone marrow and enhance their release into the bloodstream. In a small 2000 human study (four healthy men, six weeks, no placebo group), white blood cell counts rose significantly after supplementation. This effect is particularly valuable for individuals with leukopenia or those recovering from chemotherapy, radiation, or chronic illness where white blood cell counts are suppressed.
• Phagocytosis activation: One of the most consistently demonstrated effects of cat's claw is the enhancement of phagocytosis, the process by which neutrophils, macrophages, and other immune cells engulf and destroy bacteria, viruses, and cellular debris. Laboratory studies, the first published in 1985, describe a phagocytosis-stimulating action of the cat's claw alkaloids, meaning that immune cells become more efficient at engulfing and eliminating pathogens. This mechanism is particularly important because it amplifies the body's existing immune infrastructure rather than replacing it.
• T-cell and natural killer (NK) cell support: Cat's claw stimulates the proliferation and activity of T-lymphocytes, including both helper T-cells (CD4+) that coordinate immune responses and cytotoxic T-cells (CD8+) that directly kill infected cells. Natural killer (NK) cell activity is also enhanced, providing improved innate immune surveillance against both infected cells and abnormal cells. Research has shown that cat's claw extracts can increase lymphocyte proliferation in response to mitogens, indicating enhanced capacity for mounting adaptive immune responses.
• Cytokine modulation: Cat's claw exhibits sophisticated immunomodulatory activity, enhancing the production of pro-inflammatory cytokines such as interleukin-1 (IL-1) and interleukin-6 (IL-6) when immune stimulation is needed, while simultaneously inhibiting excessive cytokine production through NF-kB modulation. This balanced effect means that cat's claw promotes effective immune responses against infections without triggering the excessive inflammation and cytokine cascades that can cause tissue damage and impair recovery.
• Complement system activation: Research has indicated that cat's claw compounds activate the complement cascade, a series of plasma proteins that enhance the ability of antibodies and phagocytic cells to clear pathogens. Complement activation facilitates bacterial opsonization (marking bacteria for destruction), membrane attack complex formation (directly lysing bacterial cells), and inflammatory signaling that recruits additional immune cells to sites of infection.

Anti-Inflammatory and Antibacterial Synergy

One of the most therapeutically important aspects of cat's claw is the synergistic relationship between its anti-inflammatory and immune-enhancing properties. This dual action distinguishes it from both conventional antibiotics (which have no anti-inflammatory effect) and conventional anti-inflammatory drugs (which can suppress immune function).

• NF-kB inhibition: Cat's claw is one of the most potent natural inhibitors of nuclear factor kappa-B (NF-kB) identified in botanical research. NF-kB is a master regulator of inflammation that, when chronically activated, drives excessive production of inflammatory mediators, tissue destruction, and paradoxically, impaired immune function. By inhibiting NF-kB, cat's claw reduces the destructive aspects of chronic inflammation while preserving and enhancing the beneficial acute immune responses needed to fight infection. Studies have shown that cat's claw alkaloids can inhibit NF-kB activation by up to 65-85% at therapeutic concentrations.
• Tumor necrosis factor-alpha reduction: Tumor necrosis factor-alpha is a potent pro-inflammatory cytokine that, when produced in excess, contributes to tissue damage, fever, cachexia, and septic shock during severe infections. Cat's claw extracts significantly reduce tumor necrosis factor-alpha production, helping to prevent the collateral tissue damage that accompanies aggressive immune responses while maintaining the targeted antibacterial activity of phagocytes and lymphocytes. This effect has been documented in both in vitro studies and clinical trials.
• How reduced inflammation aids infection recovery: Chronic inflammation creates a paradoxical state in which the immune system is simultaneously overactive (producing tissue damage) and underperforming (failing to effectively eliminate pathogens). By resolving this inflammatory dysregulation, cat's claw enables the immune system to function more efficiently. Reduced tissue inflammation improves blood flow to infected areas, enhances the delivery of immune cells and nutrients, promotes tissue repair, and creates a less favorable environment for bacterial survival. This is why cat's claw has historically been most effective for chronic and recurring infections rather than acute overwhelming infections.
• Prostaglandin and cyclooxygenase-2 (COX-2) modulation: Cat's claw compounds inhibit cyclooxygenase-2 (COX-2) activity and reduce prostaglandin E2 production, providing anti-inflammatory effects similar to non-steroidal anti-inflammatory drugs but without the gastrointestinal side effects. This prostaglandin modulation further reduces inflammatory swelling and pain at infection sites while supporting immune-mediated bacterial clearance.

Lyme Disease and Tick-Borne Infections

Cat's claw has gained significant attention in the integrative medicine community for its potential role in treating Lyme disease and co-infections caused by tick-borne pathogens. While clinical evidence remains preliminary, the mechanisms of action and anecdotal clinical experience have made it a widely used component of integrative Lyme treatment protocols.

• Borrelia burgdorferi research: Borrelia burgdorferi, the spirochetal bacterium that causes Lyme disease, is notoriously difficult to eradicate due to its ability to change morphological forms, evade immune detection, and persist in intracellular locations. Laboratory research has investigated cat's claw extracts against Borrelia in various morphological forms, including spirochetes, round bodies (cysts), and biofilm aggregates. Lyme practitioners report that a whole-herb cat's claw preparation is active against all three forms of Borrelia burgdorferi, a point they stress because standard antibiotic therapy primarily targets the spirochetal (spiral) form.
• Biofilm disruption potential: Borrelia burgdorferi produces robust biofilms that protect bacterial colonies from both immune attack and antibiotic penetration. Biofilm-associated bacteria can be up to 1,000 times more resistant to antibiotics than their planktonic (free-floating) counterparts. Cat's claw compounds, particularly proanthocyanidins, have shown potential to disrupt biofilm architecture and enhance the penetration of other antimicrobial agents. This biofilm-disrupting capability is one reason cat's claw is often used in combination with other antimicrobial herbs and conventional antibiotics in integrative Lyme protocols.
• Integrative Lyme protocols: Several prominent integrative medicine physicians have incorporated cat's claw into their Lyme disease treatment protocols. Dr. Lee Cowden developed the widely used "Cowden Protocol," which features a rotation of herbal extracts including cat's claw (a preparation specifically selected for pentacyclic oxindole alkaloid content and absence of tetracyclic alkaloids). Stephen Buhner's herbal protocol for Lyme disease also includes cat's claw as a core immune-modulating herb. In these protocols, cat's claw is typically used alongside other antimicrobial herbs such as andrographis, Japanese knotweed, and cryptolepis to address the multi-system nature of chronic Lyme disease.
• Co-infection support: Patients with Lyme disease frequently harbor co-infections with other tick-borne pathogens including Babesia, Bartonella, Anaplasma, and Ehrlichia species. Cat's claw's broad immune-enhancing activity is considered beneficial for supporting the body's ability to address these multiple simultaneous infections. Its anti-inflammatory effects are also valuable for managing the systemic inflammation and neuroinflammation that characterize chronic tick-borne illness.

Gastrointestinal Health

Cat's claw has deep traditional roots in the treatment of gastrointestinal complaints, and modern research has validated many of these traditional applications. The plant's combination of antimicrobial, anti-inflammatory, and mucosal-healing properties makes it particularly well-suited for addressing disorders of the digestive tract.

• Helicobacter pylori: Herbal practitioners use cat's claw against H. pylori, describing both direct antimicrobial effects and enhancement of immune defenses in the gastric mucosa. While cat's claw alone may not be sufficient to eradicate H. pylori infection, it is often used as an adjunct to conventional triple therapy or as part of a comprehensive herbal protocol that may include mastic gum, berberine-containing herbs, and broccoli sprouts.
• Leaky gut and intestinal permeability: Increased intestinal permeability, often referred to as "leaky gut," allows bacteria, toxins, and undigested food particles to pass through the intestinal barrier into the bloodstream, triggering systemic inflammation and immune activation. Cat's claw's anti-inflammatory activity, particularly its NF-kB inhibition, helps reduce the inflammatory damage to tight junctions between intestinal epithelial cells. The proanthocyanidins in cat's claw also exert astringent and tissue-toning effects on the gut lining, supporting the restoration of barrier integrity.
• Crohn's disease: Practitioners use cat's claw for active Crohn's disease and report improvements in symptoms and quality of life. They attribute the benefits to cat's claw's NF-kB inhibitory and anti-inflammatory effects, which they see as addressing the immune dysregulation that drives Crohn's disease. While larger controlled trials are needed, these preliminary reports are encouraging for a condition with limited treatment options.
• Gut barrier repair: Cat's claw supports the repair and maintenance of the gastrointestinal mucosa through multiple mechanisms. Its anti-inflammatory effects reduce the immune-mediated damage that erodes the gut lining. Proanthocyanidins strengthen the mucosal barrier by cross-linking collagen fibers and promoting mucus production. The plant's antioxidant compounds protect intestinal epithelial cells from oxidative stress, while its immune-modulating activity helps normalize the gut-associated lymphoid tissue (GALT), which constitutes approximately 70% of the body's immune system.
• Digestive inflammation: Beyond specific conditions, cat's claw is used for general gastritis, colitis, and diverticulitis. Its ability to reduce inflammation throughout the digestive tract while simultaneously supporting immune function and mucosal repair makes it a comprehensive gastrointestinal tonic. Traditional Amazonian healers specifically recommended cat's claw bark decoctions for stomach pain, dysentery, and intestinal parasites.

DNA Repair and Cellular Protection

One of the most distinctive properties of cat's claw, setting it apart from most other medicinal herbs, is its documented ability to enhance DNA repair mechanisms. This property has significant implications for immune function, cellular health, and the body's ability to combat infections.

• Enhancing DNA repair mechanisms: A small clinical study published in Phytomedicine in 2001 by Sheng et al. examined the effects of a water-soluble (hot-water) extract of cat's claw bark on DNA repair in 12 healthy volunteers. After eight weeks of supplementation at 250-350 mg daily, the supplemented participants showed significantly enhanced DNA repair capacity as measured by reduced DNA damage in peripheral blood lymphocytes following hydrogen peroxide challenge. The researchers concluded that cat's claw extract promotes DNA repair through enhancement of base excision repair (BER) and nucleotide excision repair (NER) pathways.
• Immune function implications: DNA repair capacity is directly linked to immune function because immune cells, particularly lymphocytes, undergo rapid proliferation when mounting responses to infections. Cells with damaged DNA may proliferate poorly, undergo apoptosis (programmed cell death), or function abnormally. By enhancing DNA repair, cat's claw ensures that immune cells maintain genomic integrity during the rapid proliferation required for effective immune responses. This means more functional T-cells, B-cells, and natural killer cells are available to fight bacterial infections.
• Protection against oxidative DNA damage: During immune responses, phagocytic cells generate reactive oxygen species (ROS) to kill bacteria. While this oxidative burst is essential for pathogen destruction, it also causes collateral oxidative damage to the DNA of surrounding immune cells and tissues. Cat's claw's antioxidant compounds, combined with its DNA repair enhancement, provide a dual protective mechanism: reducing oxidative damage while simultaneously improving the repair of damage that does occur.
• Leukocyte lifespan extension: Research has shown that cat's claw supplementation is associated with reduced apoptosis (programmed cell death) in white blood cells. By preventing premature leukocyte death, cat's claw effectively increases the number and longevity of immune cells available to combat infections. This effect is particularly relevant for elderly individuals or those with chronic illness, where accelerated immune cell apoptosis contributes to immunosenescence and increased infection susceptibility.

Two Chemotypes

A critical but often overlooked aspect of cat's claw therapeutics is the existence of two distinct chemotypes within the species Uncaria tomentosa. These chemotypes produce different alkaloid profiles with opposing pharmacological effects, making chemotype identification essential for therapeutic use.

• Pentacyclic oxindole alkaloid (POA) chemotype: This chemotype produces predominantly pentacyclic oxindole alkaloids, including isopteropodine, pteropodine, mitraphylline, and speciophylline. The POA chemotype is the therapeutically desirable form for immune enhancement and antibacterial support. Pentacyclic alkaloids stimulate immune function by enhancing phagocytosis, increasing lymphocyte proliferation, and modulating cytokine production. The vast majority of clinical research demonstrating cat's claw's immune-enhancing and anti-inflammatory effects has been conducted using POA-dominant extracts.
• Tetracyclic oxindole alkaloid (TOA) chemotype: This chemotype produces predominantly tetracyclic oxindole alkaloids, including rhynchophylline and isorhynchophylline. Critically, a 1998 laboratory study by Wurm and colleagues (Laus and Keplinger among the authors) found that tetracyclic alkaloids dose-dependently reduce the activity of pentacyclic alkaloids on human endothelial cells, and a 1999 review led by Keplinger describes tetracyclic alkaloids as antagonists of the pentacyclic ones. Tetracyclic alkaloids have their own therapeutic properties, including effects on the central nervous system and cardiovascular system, but they work against the immune-stimulating goals for which cat's claw is most commonly used.
• Why chemotype matters for therapeutic use: Because the two chemotypes are visually indistinguishable in the field and even under microscopic examination, laboratory analysis is required to determine the alkaloid profile of any given cat's claw harvest. Standardized pharmaceutical-grade cat's claw products, such as those used in clinical studies, are typically tested and certified to contain predominantly pentacyclic alkaloids with minimal tetracyclic alkaloid contamination. Products labeled as "TOA-free" or "POA-standardized" have undergone this quality verification. Because the immune research used extracts of the pentacyclic type, this labelling shows whether a product matches the material that was studied. For individuals seeking immune enhancement or antibacterial support, selecting a POA-standardized product is essential for achieving the desired therapeutic outcome.
• Species distinction: It is also important to distinguish Uncaria tomentosa from Uncaria guianensis, a related species sometimes sold as cat's claw. While U. guianensis has its own medicinal properties, it has a different alkaloid profile and has not been the subject of the same depth of research regarding immune enhancement and antibacterial activity. The species name on the label (Uncaria tomentosa or Uncaria guianensis) shows which plant a product contains.

Synergistic Effects

Cat's claw is frequently used in combination with other immune-enhancing and antimicrobial herbs. Research and clinical practice have identified several particularly effective synergistic combinations that amplify the antibacterial and immune-supporting effects beyond what any single herb can achieve alone.

• With echinacea (Echinacea purpurea and E. angustifolia): Echinacea is among the most well-studied immune-enhancing herbs, and its combination with cat's claw creates a complementary immune activation profile. Echinacea primarily enhances innate immune function through activation of macrophages, natural killer cells, and complement pathways, and it increases properdin levels. Cat's claw adds its unique NF-kB modulation, DNA repair enhancement, and T-cell stimulation. Together, these herbs provide broad-spectrum immune activation spanning both innate and adaptive immunity. This combination is particularly effective for preventing and treating upper respiratory infections, where Echinacea provides rapid-onset immune stimulation while cat's claw contributes sustained immune modulation.
• With astragalus (Astragalus membranaceus): Astragalus is a premier Qi-tonic herb in Traditional Chinese Medicine, renowned for its deep immune-building and adaptogenic properties. When combined with cat's claw, astragalus provides complementary support through its polysaccharide-mediated immune enhancement, telomerase activation, and bone marrow stimulation. While cat's claw excels at acute immune activation and anti-inflammatory modulation, astragalus specializes in long-term immune reconstitution and resilience. This combination is especially valuable for individuals recovering from prolonged illness, those with chronic fatigue and immune dysfunction, or patients undergoing treatments that suppress bone marrow function.
• With andrographis (Andrographis paniculata): Andrographis, sometimes called "Indian echinacea" or "king of bitters," provides potent direct antibacterial activity through its active compound andrographolide. When combined with cat's claw, the two herbs address infection from complementary angles: andrographis contributes strong direct antimicrobial effects and rapid symptom relief, while cat's claw provides immune system amplification and anti-inflammatory support that prevents infection recurrence. This combination has been used in integrative protocols for respiratory infections, urinary tract infections, and Lyme disease, where the direct bactericidal effects of andrographis complement cat's claw's immune-mediated antibacterial activity.
• With oregano and berberine-containing herbs: For gastrointestinal infections and small intestinal bacterial overgrowth (SIBO), cat's claw is frequently combined with oregano oil, berberine (from goldenseal, Oregon grape, or barberry), and other directly antimicrobial botanicals. Cat's claw contributes immune enhancement and gut-healing effects while the antimicrobial herbs provide direct pathogen reduction. This layered approach addresses both the infection and the underlying immune and mucosal dysfunction that permitted the infection to develop.

Other Health Benefits

Beyond its antibacterial and immune-enhancing properties, cat's claw has demonstrated a broad spectrum of health benefits that contribute to overall wellness and resilience against disease.

• Antiviral activity: Cat's claw extracts have demonstrated activity against several viruses, including herpes simplex virus (HSV), dengue virus, and equine encephalitis virus. Research has shown that quinovic acid glycosides and certain alkaloids interfere with viral replication and attachment to host cells. Cat's claw's immune enhancement also supports the body's antiviral defenses through increased natural killer cell and cytotoxic T-cell activity, which are critical for eliminating virus-infected cells.
• Anti-inflammatory effects: Beyond its role in infection management, cat's claw is used extensively for inflammatory conditions including rheumatoid arthritis, osteoarthritis, and other musculoskeletal disorders. In a 2001 trial published in Inflammation Research, 45 people with knee osteoarthritis took a freeze-dried extract of the related species Uncaria guianensis (30 people) or a placebo (15 people) for four weeks; pain during activity and the doctors' and patients' assessment scores fell significantly, with benefits within the first week, while pain at rest or at night and knee swelling (knee circumference) were not significantly reduced. These effects are attributed to NF-kB inhibition, tumor necrosis factor-alpha reduction, and cyclooxygenase-2 modulation.
• Antioxidant properties: Cat's claw demonstrates significant free radical scavenging activity, with studies showing its antioxidant potency comparable to or exceeding that of many well-known antioxidant herbs. The proanthocyanidins, catechins, and other phenolic compounds neutralize reactive oxygen species (ROS), reduce lipid peroxidation, and protect cellular membranes from oxidative damage. These antioxidant effects are synergistic with the plant's DNA repair enhancement, providing comprehensive cellular protection.
• Joint health: Small clinical trials have reported less joint pain in osteoarthritis and rheumatoid arthritis. In a 2002 trial by Mur et al. in the Journal of Rheumatology, 40 people with active rheumatoid arthritis who were already taking sulfasalazine or hydroxychloroquine took an extract of the pentacyclic chemotype or a placebo for 24 weeks: the number of painful joints fell by 53.2% on the extract against 24.1% on placebo. Swollen joints improved only in the trial's second, open phase, among patients who switched from placebo to the extract, compared with their own results after placebo. The authors called it a small preliminary study showing a modest benefit to the tender joint count. The mechanism involves tumor necrosis factor-alpha suppression, reduced prostaglandin production, and decreased synovial inflammation.
• Cognitive support: Emerging research suggests that cat's claw may provide neuroprotective benefits relevant to cognitive health. Studies have shown that cat's claw extracts can reduce the formation and accumulation of beta-amyloid plaques, a hallmark of Alzheimer's disease. The plant's anti-inflammatory and antioxidant effects also protect neurons from inflammatory and oxidative damage. A proanthocyanidin-rich cat's claw extract developed for Alzheimer's research has shown particular promise in preclinical Alzheimer's research, reducing brain plaques and tangles while improving memory in animal models.

Forms and Preparations

Cat's claw is available in various preparations, each with distinct advantages and appropriate applications. The inner bark of the vine is the primary medicinal part used, though the root bark is also employed in traditional medicine.

• Inner bark (primary medicinal source): The inner bark of the cat's claw vine contains the highest concentration of bioactive alkaloids, quinovic acid glycosides, and proanthocyanidins. It is harvested by stripping the outer bark to reveal the inner layer, which is then dried and processed. Sustainable harvesting practices involve taking bark from lateral roots and lower portions of the vine, allowing the plant to regenerate. Some products state "inner bark" (corteza interior) on the label; whole bark may contain lower alkaloid concentrations.
• Capsules: Standardized capsules are the most convenient and precise form of cat's claw supplementation. They are commonly standardized to a stated percentage of total oxindole alkaloids (typically 3-5%), and some are verified as pentacyclic alkaloid-dominant (POA). Capsules provide consistent dosing and are suitable for long-term supplementation. They are typically available in 250-500 mg strengths, with some products offering higher potency 1000 mg capsules.
• Tincture (liquid extract): Alcohol-based tinctures (usually 1:5 ratio in 45-60% ethanol) offer good bioavailability because the alcohol efficiently extracts the alkaloid and glycoside fractions. Tinctures allow flexible dosing and are absorbed more rapidly than capsules. Glycerin-based tinctures (glycerites) are available for people who abstain from alcohol but may extract fewer alkaloids. Tinctures are particularly convenient for combining cat's claw with other immune-supporting herbs in customized formulas.
• Tea and decoction: Traditional Amazonian preparation involves simmering inner bark in water for 30-60 minutes to create a decoction. This method extracts water-soluble compounds including some alkaloids, glycosides, and proanthocyanidins, though it may be less efficient at extracting certain alkaloids compared to alcohol-based preparations. Tea preparation typically uses 1-2 tablespoons of dried inner bark per cup of water. The decoction has a mild, slightly woody taste that is generally well-tolerated. Longer simmering times produce stronger preparations, though the excessive heat of a hard boil may degrade certain active compounds.
• Standardized extract: Standardized extracts are the forms used in clinical research. The most researched are a water-soluble (hot-water) extract used in the DNA-repair and immune studies and a concentrated extract rich in carboxy alkyl esters. Such extracts are tested for alkaloid content, chemotype, and absence of adulterants. They cost more than plain bark; their advantage is that they match the material used in the published studies.

Doses Used in Studies and Practice

Doses of cat's claw vary with the preparation form, concentration, and intended use. The figures below come from traditional usage, clinical trial protocols, and practitioner experience. Cat's claw has been reported to interact with HIV medicines, and in laboratory tests an extract blocked CYP3A4, a liver enzyme that breaks down many other medicines; these findings are described under Safety and Contraindications below.

• Standardized extract (capsules): 250-350 mg daily of a standardized extract (such as the water-soluble extract used in the trials) for general immune support and maintenance. For acute immune challenges or as part of an infection-fighting protocol, doses of 300-500 mg daily are commonly used. Clinical trials have primarily used doses in the 250-350 mg daily range for standardized extracts, with benefits observed after 4-8 weeks of consistent use.
• Bark powder (capsules): 500-1000 mg of dried inner bark powder, taken two to three times daily with meals, for a total daily dose of 1000-3000 mg. Higher doses within this range are typically used during acute illness, and lower maintenance doses for ongoing immune support. Some practitioners use doses up to 5000 mg daily for short periods during active infections.
• Tincture (1:5): 1-2 mL (approximately 20-40 drops) taken two to three times daily. The tincture can be taken directly under the tongue for faster absorption or diluted in a small amount of water. For acute conditions, doses of up to 3 mL three times daily may be used. Practitioners describe holding the tincture in the mouth for 30-60 seconds before swallowing, for absorption of the alkaloids under the tongue.
• Tea and decoction preparation: The usual decoction is 1-2 tablespoons (5-10 grams) of dried inner bark simmered in 2-3 cups of water for 30-45 minutes, strained, and divided into 2-3 servings through the day. It keeps in the refrigerator for up to 48 hours. A stronger preparation uses 3 tablespoons of bark simmered for up to one hour. Traditional Amazonian healers often prepared much stronger decoctions, using large quantities of bark simmered for several hours; these concentrated preparations were made and given by the healers themselves.
• Duration of use: For general immune support, cat's claw can be taken continuously for periods of 8-12 weeks, followed by a 2-4 week break. For chronic conditions such as Lyme disease or autoimmune-related issues, practitioners describe longer treatment courses of 3-6 months or more. Some herbalists recommend cycling cat's claw with other immune-supporting herbs to prevent immune adaptation and maintain therapeutic effectiveness.

Safety and Contraindications

Cat's claw has a long history of safe traditional use and has demonstrated a favorable safety profile in clinical trials. However, its potent immune-modulating and anti-inflammatory effects necessitate awareness of specific contraindications and precautions.

• Autoimmune diseases: Because cat's claw stimulates and modulates immune function, its use raises a concern for people with autoimmune conditions such as lupus, multiple sclerosis, rheumatoid arthritis, or Hashimoto's thyroiditis. While cat's claw's NF-kB modulation may theoretically benefit some autoimmune conditions by reducing inflammatory drive, its immune-stimulating effects could potentially exacerbate others. Paradoxically, some clinical studies have shown benefit in rheumatoid arthritis; in the 2002 trial the patients were already taking standard rheumatoid arthritis medicines (sulfasalazine or hydroxychloroquine), and their painful and swollen joints were counted throughout.
• Organ transplant and immunosuppressant medications: Cat's claw is strictly contraindicated for individuals taking immunosuppressant drugs following organ transplantation. The herb's immune-enhancing effects could counteract the action of drugs such as cyclosporine, tacrolimus, sirolimus, and mycophenolate, potentially triggering organ rejection. This contraindication also applies to individuals taking immunosuppressants for any reason, including severe autoimmune disease management.
• Pregnancy and breastfeeding: Cat's claw is contraindicated during pregnancy due to its traditional use as a contraceptive and abortifacient by Amazonian indigenous groups. Historical reports indicate that Ashaninka women used cat's claw preparations to prevent and terminate pregnancy. While the specific doses and preparations used for this purpose were likely much stronger than modern supplements, there is no safety data supporting its use in pregnancy. There is also no good safety data on breastfeeding, including whether the alkaloids pass into breast milk.
• Blood thinners and anticoagulant medications: Cat's claw may have mild antiplatelet effects that could theoretically potentiate the action of anticoagulant and antiplatelet medications including warfarin, heparin, aspirin, clopidogrel, and direct oral anticoagulants. Clinically significant bleeding interactions have not been widely reported; the concern is theoretical, and it matters most for people taking blood-thinning medicines, whose clotting is checked with blood tests (such as the INR for warfarin).
• HIV medicines and other drugs broken down by the liver: A 2008 report in the European Journal of Clinical Pharmacology describes an interaction between cat's claw and the HIV protease inhibitors atazanavir, ritonavir and saquinavir. In a 2018 laboratory study, a cat's claw extract used in Lyme protocols blocked about 40% of the activity of CYP3A4, a liver enzyme that breaks down many common medicines, and strongly switched on PXR, a cell sensor that turns up the body's drug-processing genes. Both effects can change the blood levels of other medicines; the study's author noted that clinical studies are needed to show whether these laboratory effects matter in people.
• Surgery preparation: Because of its potential antiplatelet effects, the usual precaution is stopping cat's claw at least 2-3 weeks before scheduled surgery to lower the risk of excessive bleeding, and surgeons and anesthesiologists ask about herbal supplements such as cat's claw at presurgical consultations for this reason. Supplementation is typically resumed 1-2 weeks after surgery, once wound healing is well established.
• Antihypertensive medications: Cat's claw has demonstrated mild blood pressure-lowering effects in some studies. In people taking blood-pressure medicines, the effects could add together and lower blood pressure further.
• Common side effects: Cat's claw is generally well-tolerated at the doses used in studies. The most commonly reported side effects are mild and include nausea, diarrhea, stomach discomfort, and headache. These effects typically resolve with dose reduction or by taking the supplement with food. Allergic reactions are rare but possible, particularly in individuals with allergies to plants in the Rubiaceae family.

Key Research Papers

1. Sheng Y, Bryngelsson C, Pero RW. "Enhanced DNA repair, immune function and reduced toxicity of C-MED-100, a novel aqueous extract from Uncaria tomentosa." Journal of Ethnopharmacology, 2000; 69(2): 115-126.
2. Wurm M, Kacani L, Laus G, Keplinger K, Dierich MP. "Pentacyclic oxindole alkaloids from Uncaria tomentosa induce human endothelial cells to release a lymphocyte-proliferation-regulating factor." Planta Medica, 1998; 64(8): 701-704.
3. Aquino R, De Feo V, De Simone F, Pizza C, Cirino G. "Plant metabolites. New compounds and anti-inflammatory activity of Uncaria tomentosa." Journal of Natural Products, 1991; 54(2): 453-459.
4. Sandoval M, Charbonnet RM, Okuhama NN, et al. "Cat's claw inhibits TNF-alpha production and scavenges free radicals: role in cytoprotection." Free Radical Biology and Medicine, 2000; 29(1): 71-78.
5. Piscoya J, Rodriguez Z, Bustamante SA, et al. "Efficacy and safety of freeze-dried cat's claw in osteoarthritis of the knee: mechanisms of action of the species Uncaria guianensis." Inflammation Research, 2001; 50(9): 442-448.
6. Mur E, Hartig F, Eibl G, Schirmer M. "Randomized double blind trial of an extract from the pentacyclic alkaloid-chemotype of Uncaria tomentosa for the treatment of rheumatoid arthritis." Journal of Rheumatology, 2002; 29(4): 678-681.
7. Keplinger K, Laus G, Wurm M, Dierich MP, Teppner H. "Uncaria tomentosa (Willd.) DC. — ethnomedicinal use and new pharmacological, toxicological and botanical results." Journal of Ethnopharmacology, 1999; 64(1): 23-34.
8. Sandoval-Chacon M, Thompson JH, Zhang XJ, et al. "Antiinflammatory actions of cat's claw: the role of NF-kappaB." Alimentary Pharmacology and Therapeutics, 1998; 12(12): 1279-1289.
9. Domingues A, Sartori A, Golim MA, et al. "Prevention of experimental diabetes by Uncaria tomentosa extract: Th2 polarization, regulatory T cell preservation or both?" Journal of Ethnopharmacology, 2011; 137(1): 635-642.
10. Heitzman ME, Neto CC, Winiarz E, Vaisberg AJ, Hammond GB. "Ethnobotany, phytochemistry and pharmacology of Uncaria (Rubiaceae)." Phytochemistry, 2005; 66(1): 5-29.
11. Snow AD, Castillo GM, Nguyen BP, et al. "The Amazon rain forest plant Uncaria tomentosa (cat's claw) and its specific proanthocyanidin constituents are potent inhibitors and reducers of both brain plaques and tangles." Scientific Reports, 2019; 9: 561.
12. Sheng Y, Li L, Holmgren K, Pero RW. "DNA repair enhancement of aqueous extracts of Uncaria tomentosa in a human volunteer study." Phytomedicine, 2001; 8(4): 275-282. — PubMed PMID: 11515717
13. López Galera RM, Ribera Pascuet E, Esteban Mur JI, Montoro Ronsano JB, Juárez Giménez JC. "Interaction between cat's claw and protease inhibitors atazanavir, ritonavir and saquinavir." European Journal of Clinical Pharmacology, 2008; 64(12): 1235-1236. — PubMed PMID: 18712519
14. Weiss J. "Herb-drug interaction potential of anti-Borreliae effective extracts from Uncaria tomentosa (Samento) and Otoba parvifolia (Banderol) assessed in vitro." Molecules, 2018; 24(1): 137. — PubMed PMID: 30602711

PubMed Topic Searches

The following are topic-level PubMed search links covering the main evidence streams for Cat's Claw (Uncaria tomentosa). Each link resolves to a curated PubMed query so that the most current randomized trials, meta-analyses, and mechanistic studies can be reviewed directly from the National Library of Medicine.

1. Mur E, Hartig F, Eibl G, Schirmer M. "Randomized double blind trial of an extract from the pentacyclic alkaloid-chemotype of Uncaria tomentosa for the treatment of rheumatoid arthritis." Journal of Rheumatology, 2002; 29(4): 678-681. — PubMed PMID: 11950006
2. Piscoya J, Rodriguez Z, Bustamante SA, Okuhama NN, Miller MJ, Sandoval M. "Efficacy and safety of freeze-dried cat's claw in osteoarthritis of the knee: mechanisms of action of the species Uncaria guianensis." Inflammation Research, 2001; 50(9): 442-448. — PubMed PMID: 11603848
3. Immunomodulatory effects of cat's claw alkaloids. — PubMed: Uncaria tomentosa immune modulation
4. Cat's claw and NF-kB inhibition. — PubMed: Uncaria tomentosa anti-inflammatory NF-kB
5. Antiviral activity of Uncaria tomentosa extracts. — PubMed: Uncaria tomentosa antiviral
6. Pentacyclic oxindole alkaloids: pharmacology and immunology. — PubMed: pentacyclic oxindole alkaloids Uncaria
7. DNA repair enhancement by Uncaria tomentosa water extract. — PubMed: Uncaria tomentosa DNA repair
8. Preclinical antitumor activity of cat's claw extracts. — PubMed: Uncaria tomentosa cancer apoptosis
9. Uncaria tomentosa and Borrelia: in vitro evidence. — PubMed: Uncaria tomentosa Lyme disease borrelia
10. Antioxidant pharmacology of Uncaria tomentosa. — PubMed: Uncaria tomentosa antioxidant
11. Safety and tolerability of cat's claw in clinical trials. — PubMed: Uncaria tomentosa safety clinical

External Authoritative Resources

1. NCCIH — Herbs at a Glance
2. MedlinePlus — Herbs and Supplements
3. PubMed — All research on Uncaria tomentosa

Back to Table of Contents

Connections

• All Herbs
• Cat's Claw Benefits Deep Dive
• Andrographis
• Arthritis
• Echinacea
• Turmeric
• Japanese Knotweed
• Immune Boosting
• Ginger
• Lyme Disease
• Crohn's Disease
• Urinary Tract Infections
• Cancer
• Goldenseal
• Astragalus
• Berberine
• Gut-Brain Axis
• Tick Bite First Aid and Prophylaxis
• Antibiotic Treatment Protocols
• Erythema Migrans Rash Guide
• Conditions on this site that reference this page: Lyme Disease Testing Explained · Herbs and Supplements for Rheumatoid Arthritis

Back to Table of Contents

Back to Table of Contents

Featured Videos

×